As the life sciences industry continues to evolve, the ability to effectively manage and leverage preclinical CRO ...
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has ...
Clinical development programs now take 2 years longer than they did a decade ago, yet many delays are predictable and preventable. Join us to explore how sponsors can accelerate critical decisions, ...
In today's ACT Brief, we examine why seizure reduction misses what families want from epilepsy trials, how lab coordination ...
Clinical trials have spent decades perfecting data capture, but the execution layer underneath it, including decision ...
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, describes how shifting patient engagement from protocol review to endpoint selection transforms ...
True lab orchestration isn't about coordinating instruments, it's about connecting scientific intent, data, and decisions ...
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, explains why the full ...
In today's ACT Brief, we examine why black-box AI fails in clinical trials, how participant understanding drives engagement ...
In today's ACT Brief, we examine genuine patient partnership in trial design, how AI enables informed recruitment while ...
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, explains why the full burden of developmental and epileptic encephalopathies extends far beyond ...
True lab orchestration isn't about coordinating instruments, it's about connecting scientific intent, data, and decisions across the entire research lifecycle.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results